A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer

Research output: Contribution to journal › Published meeting abstract

Details

Authors
  • S Margolin
  • L Carlsson
  • M Hellström
  • P Karlsson
  • E Lidbrink
  • B Linderholm
  • H Lindman
  • Per Malmström
  • D Sköld Pettersson
  • J Bergh
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)116-117
JournalEuropean Journal of Cancer Supplements
Volume6
Issue number7
Publication statusPublished - 2008
Publication categoryResearch
Peer-reviewedYes
EventEBCC-6, European Breast Cancer Conference, 2008 - Berlin, Germany
Duration: 2008 Apr 14 → 2008 Apr 19

DOI